Effectiveness of Adriamycin Questioned in the Treatment of Patients With HER2-Positive Breast Cancer

Links shared publicly online about this topic.

  • 0
    total visits

Effectiveness of Adriamycin Questioned in the Treatment of Patients With HER2-Positive Breast Cancer

onclive.com

HER2-positive women can be effectively treated with Herceptin (trastuzumab injection) without the use of Adriamycin.

View full resource at onclive.com

Tags: Cancer, Breast Cancer, Breast Cancer Medication, Women's Health, Herceptin

  • Share

Most Recently Shared on October 15, 2011 at 2:00 pm By:

ONClive Editor

Effectiveness of Adriamycin Questioned in the Treatment of Patients With HER2-Positive Breast Cancer http://t.co/FI4K6SuN

7 months ago...

Advertisement